← Eichor
Study identifier: NCT07189078 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

IntHyx : Intubation Strategies for Patients With Acute Hypoxemic Respiratory Failure

Condition: Acute Hypoxemic Respiratory Failure  ·  Sponsor: University Hospital, Angers

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Acute hypoxemic respiratory failure requires endotracheal intubation and invasive mechanical ventilation in approximately 30-40% of cases, due to severe hypoxemia and/or clinical signs of acute respiratory distress. The primary objectives of invasive mechanical ventilation are to reduce respiratory effort and improve oxygenation. However, this intervention is also associated with both direct and indirect adverse effects, mainly linked to the need for sedation and often neuromuscular blockade. These include hemodynamic compromise, neuromuscular weakness, ventilator-induced lung injury, and infectious complications. An ideal intubation strategy would therefore strike a balance: avoiding the risks of delayed intubation-such as refractory hypoxemia, excessive respiratory effort, and patient self-inflicted lung injury (P-SILI)-while limiting complications associated with invasive mechanical ventilation by withholding it in patients who might otherwise recover without. To date, the optimal strategy for achieving this risk-benefit balance remains uncertain. Clinical practice suggests a broad consensus on the necessity of intubation when so-called safety criteria are met: severe hypoxemia (SaO₂/FiO₂ ratio \< 88), marked respiratory distress (use of accessory muscles, thoracoabdominal paradox, respiratory rate \> 40/min), extra-respiratory manifestations of hypoxia (e.g., altered consciousness), and/or uncontrolled hemodynamic instability. Beyond these safety thresholds, however, de…

This description comes directly from the study's public registry record.

Talk to the study team

Mathilde TAILLANTOU-CANDAU, Doctor  ·  +33 (0)2 41 35 58 65  ·  Mathilde.Taillantou-candau@chu-angers.fr

Matthieu Le Lay  ·  +33 (0)2 41 35 58 91  ·  DRCI-Promotion-Interne@chu-angers.fr

Always discuss trial participation with your own doctor first.

Locations (9)

Angers University Hospital, ICUAngers, FranceRecruiting
Le Mans Hospital, ICULe Mans, FranceNot Yet Recruiting
Nantes University Hospital, ICUNantes, FranceNot Yet Recruiting
Orléans University hospital, ICUOrléans, FranceNot Yet Recruiting
Pitié-Salpétrière Hospital, Paris University Hospital, ICUParis, FranceNot Yet Recruiting
Guadeloupe University Hospital, ICUPointe à Pitre, FranceNot Yet Recruiting
Rennes University Hospital, ICURennes, FranceNot Yet Recruiting
Tours University Hospital, ICUTours, FranceNot Yet Recruiting
Vannes Hospital, ICUVannes, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07189078